Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

23.37
+0.61002.68%
Post-market: 23.370.00000.00%19:40 EDT
Volume:1.55M
Turnover:36.29M
Market Cap:2.85B
PE:17.84
High:23.70
Open:23.06
Low:22.89
Close:22.76
Loading ...

Citi Remains a Buy on Catalyst Pharma (CPRX)

TIPRANKS
·
17 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
12 Apr

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Insider Monkey
·
12 Apr

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip

Simply Wall St.
·
10 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

BRIEF-Catalyst Pharmaceuticals Announces Health Canada’S Acceptance Of Agamree® New Drug Submission

Reuters
·
08 Apr

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

GlobeNewswire
·
08 Apr

Catalyst Pharmaceuticals Inc. Stock Slides 5.5%, Underperforms Competitors

Dow Jones
·
08 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
05 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?

Insider Monkey
·
02 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
02 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
01 Apr

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?

Zacks
·
28 Mar

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

Insider Monkey
·
27 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
27 Mar

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

Simply Wall St.
·
26 Mar

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Zacks
·
25 Mar